Benzinga's Top Pre-Market Gainers

Incyte (NASDAQ: INCY ) moved up 16.67% to $31.50 in the pre-market session after the company provided top-line results from Phase II proof-of-concept trial of ruxolitinib. Alaska Communications Systems Group (NASDAQ: ALSK ) surged 7.55% to $3.69 in the pre-market session. Alaska Communications' trailing-twelve-month operating margin is 20.49%. Lowe's Companies